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Abstract
Background: Hepatic sinusoidal resistance is regulated by vasoactive factors including
endothelin-1 (ET-1) and nitric oxide (NO). In the absence of NO, vasoconstrictor
response to endothelin is expected to predominate. Therefore, we hypothesized
sensitivity to endothelin to be increased in mice lacking the endothelial cell NO synthase
gene. Response of vascular resistance to endothelin was assessed in the in situ perfused
liver of endothelial constitutive nitric oxide synthase (ecNOS) knockout and wild type
mice. Livers were also harvested for RNA and protein isolation for quantitative PCR and
Western blotting, respectively. The expression of endothelin receptors, isoenzymes of
NO synthase, heme-oxygenase and adrenomedullin was quantified.
Results: Endothelin increased hepatic vascular resistance in a dose-dependent manner in
both strains; however, this increase was significantly less in ecNOS knockout mice at
physiologic concentrations. Expression of heme-oxygenases and adrenomedullin was
similar in both groups, whereas inducible nitric oxide synthase (iNOS) protein was not
detectable in either strain. mRNA levels of pre-pro-endothelin-1 and ETB receptor were
comparable in both strains, while mRNA for ETA receptor was decreased in ecNOS
knockouts.
Conclusion: Livers of ecNOS knockout mice have a decreased sensitivity to endothelin
at physiologic concentrations; this is associated with a decreased expression of ETA
receptors, but not with other factors, such as iNOS, ETB receptors, adrenomedullin or
heme-oxygenase. Further studies targeting adaptive changes in ETA receptor distribution
and/or intracellular signaling downstream of the receptor are indicated.
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Background
Sinusoidal perfusion is highly variable and regulated by
different humoral substances including nitric oxide and
endothelin [1-3]. Endothelin-1 (ET-1), one of the most
potent endogenous vasoconstrictors [4], has extra- and
intra-sinusoidal actions, the latter being more important
at low endothelin concentrations [1,5] This effect has
been associated to hepatic stellate cell contraction [6]. The
resulting increase in shear stress activates endothelial
nitric oxide (NO) production via ETB receptors [7].
Intrahepatic vascular resistance is also regulated by
vasoactive substances that may act locally or systemically.
An excess of vasoconstrictors increases the vascular tone
and may lead to an exaggerated response of the hepatic
vascular bed. These factors include noradrenaline, angi-
otensin II and leukotrienes [8], but ET-1 seems to be the
most potent one. In the rat liver, the ETA receptor subtype
causes vasoconstriction, while the ETB receptor subtype is
associated with a dual vascular response. ETB on hepatic
stellate cells mediates their constriction, but this is nor-
mally countered by the vasodilatory effect of NO, released
under the regulation of ETB on endothelial sinusoidal cells
[1].
The vascular balance is maintained by the availability of
vasodilators. NO is the best known, but other molecules
such as carbon monoxide [9] and adrenomedullin con-
tribute to intrahepatic vasodilation [10].
The release of NO has been demonstrated to be a crucial
regulatory mechanism counteracting the action of ET-1 in
the kidney of ET-1 transgenic mice, highlighting the in vivo
interaction between NO and ET-1 [11]. Additionally, an
increased NO bioavailability has been shown to improve
endothelium-dependent relaxation of aortic rings from
mice overexpressing ET-1, suggesting that, in the presence
of an activated ET system, NO production may essentially
contribute to maintain a normal vascular pressure [12].
Mice in which the key enzyme catalyzing the release of
NO, endothelial constitutive NO synthase, has been
knocked out have arterial hypertension but are otherwise
phenotypically normal [13]. We argued that the hepatic
vasculature of such mice should be more sensitive to exog-
enous endothelin-1 since the compensatory vasodilata-
tion could not occur. Therefore, vascular resistance in
response to ET-1 was studied in the perfused mouse liver
of ecNOS knockout mice and their wild type counterparts.
Surprisingly, sensitivity to ET-1 was decreased in ecNOS
knockout mice, suggesting the presence of compensatory
mechanisms counteracting the absence of NO. The
decreased hepatic expression of ETA receptors in endothe-
lial constitutive nitric oxide synthase (ecNOS) knockout
mice may contribute to the observed decreased vascular
sensitivity.
Results
General observations
All animals were tested for the presence of ecNOS. On
Western blots ecNOS was detectable in wild type, but not
in knockout mice (Fig. 1). The same held true for ecNOS
mRNA as demonstrated by real time quantitative PCR
(data not shown). We tested whether iNOS or the two
isoenzymes of heme oxygenase would compensate for the
lack of ecNOS. Inducible NOS was not detectable by West-
ern blotting in either strain [14] while the expression of
heme oxygenase 1 and 2 did not differ between the two
strains (Figs. 2a, 2b). Heme oxygenase 1 in wild type and
ecNOS knockout mice were 42 ± 11 and 42 ± 9 Linear
Arbitrary Units (LAU), respectively. Heme oxygenase 2 in
wild type and ecNOS knockout mice were 193 ± 52 and
171 ± 45 LAU, respectively. Furthermore, adrenomedullin
mRNA was probed by real-time PCR to investigate
whether it would be upregulated in the absence of NO;
there was no difference between the two groups, ∆CT aver-
aging 11.0 ± 0.5 and 11.1 ± 0.4 in wild-type and knockout
mice, respectively.
Effect of ET-1 on portal resistance
ET-1 induced a dose-dependent increase in portal per-
fusion pressure and a decrease in portal flow in both
mouse strains; this resulted in a dose-dependent increase
in hepatic vascular resistance (Fig. 3). There was an
increase in hepatic resistance in both strains; however,
this increase was significantly less marked at concentra-
tions 3 × 10-10 to 3 × 10-9 M in ecNOS knockout mice. At
higher, non-physiologic concentrations, there was no dif-
ference between ecNOS knockout and wild type mice. Via-
bility of the perfused organ as assessed by K+ and alanine
aminotransferase (ALT) release into the perfusate was not
affected in either strain (data not shown).
Expression of pre-pro-endothelin-1 and its receptors
ET-1 radioimmunoassay showed no significant difference
between the two groups, being 7 ± 6 and 12 ± 20 pg/100
Western blot of ecNOS in wild-type and ecNOS knockout  mice Figure 1
Western blot of ecNOS in wild-type and ecNOS knockout 
mice. The enzyme was not detectable in the knockouts. Data 
are from single mice and not from pools.
Pos C   KO1  KO2  KO3   KO4      WT1 WT2  WT3  WT4  Pos C
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mg liver tissue in wild-type and knockout mice, respec-
tively. The mRNA steady state levels, quantified by real-
time PCR, of pre-pro-endothelin-1 and ETB receptor were
comparable in WT and ecNOS knockout mice (Table 1).
In contrast, mRNA of ETA receptors was reduced by 65%
in ecNOS knockout mice compared to WT mice (Table 1).
Discussion
Contrary to our expectations, the present investigation
demonstrates a decreased sensitivity of the liver from
ecNOS knockout mice to exogenous ET-1. This appears to
be achieved independent of changes in other major
vasodilatory systems including inducible nitric oxide syn-
thase (iNOS), heme oxygenase and adrenomedullin.
Different factors that could compensate for the lack of
ecNOS were evaluated. The prime candidate being obvi-
ously the inducible isoform [15], it was not detectable by
Western blotting excluding its participation in the reduced
response to endothelin in ecNOS knock-out mice. Direct
assessment of NO formation by the citrulline assay [16] is
not reliable in liver tissue owing to competing enzymatic
reactions. Hence, other potential candidates were exam-
ined.
Carbon monoxide (CO) has recently been described as
another factor modulating sinusoidal tone [9]. NO and
CO may complement each other as signaling molecules in
some physiological situations [17-19]. Heme oxygenase
catalyses the production of CO from heme [17]. However,
heme oxygenase isoforms 1 and 2 were similarly
expressed in the two strains on the protein and mRNA
level, making unlikely a contribution from this system.
The same held true for adrenomedullin, a potent vasodi-
lator peptide [20] which acts in part through cAMP and in
part through ecNOS [21-26]. However, decreased NO
may theoretically reduce adrenomedullin receptor availa-
bility even if it increases adrenomedullin mRNA, since in
a rat mesangial cell culture system, NO donors increased
binding of adrenomedullin to its receptor but reduced
adrenomedullin mRNA levels [27].
Finally, we looked at the endothelin system itself.
Although endothelin was originally described as a potent
vasoconstrictor [4], depending on the particular receptor
involved it can also have vasodilatory properties. It would
have been conceivable that endothelin would be altered
in the absence of ecNOS-derived NO; this was clearly not
the case since at the protein and the mRNA level there was
no difference between the two strains.
Vasoconstriction is mediated mainly by ETA  receptors
[28], but also by ETB receptors present on smooth muscle
cells [29]. In contrast, vasodilatation is evoked via ETBre-
Western blot of heme oxygenase 1 (2a) and 2 (2b) in wild-type and ecNOS knockout mice Figure 2
Western blot of heme oxygenase 1 (2a) and 2 (2b) in wild-type and ecNOS knockout mice. There was no difference in expres-
sion between the two strains. Data are from single mice and not from pools.
Pos C     KO1  KO2   KO3   KO4     WT1   WT2   WT3   WT4 (a)
HO-1
Pos C   KO1   KO2   KO3   KO4     WT1   WT2   WT3   WT4
(b)
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ceptors through release of endothelium derived vasodila-
tors such as NO and prostacyclin [30,31] ETBreceptor
mRNA was unchanged as shown by quantitative PCR.
This suggests that ETB receptors did not contribute to
adaptive changes in ecNOS knockout mice. Furthermore,
ETB receptors are not expected to contribute to vasodilata-
tion in ecNOS knockout mice as the vasodilatory action of
ETB receptors is mediated predominantly through ecNOS.
In the ecNOS knockout mice, the expression of ETA recep-
tors was down-regulated. This observation may explain
the attenuated response to ET-1 in ecNOS knockout mice
and makes biological sense as an adaptive mechanism. In
fact, under basal conditions the portal pressure in wild
type and ecNOS knockout mice is similar, suggesting that
a decrease in vasoconstrictor mechanisms, in our model
the decrease of the expression of ETA receptors, compen-
sates for a decrease in vasodilator factors, in our model the
lack of ecNOS. However, this equilibrium is not main-
tained when a vasoactive stress, such as the perfusion of
the liver with ET-1, is applied. The use of the perfused liver
model allowed us to postulate that, in ecNOS knockout
mice, the decreased sensitivity to ET-1 is associated to an
insufficient expression of ETA receptors. Investigation of
the mechanisms by which ETA receptors contribute to the
unexpected decreased sensitivity of liver from ecNOS
knockout mice to exogenous endothelin-1 was beyond
the scope of this study. In a recent study, the expression of
ETA receptors was decreased in endothelium-denuded aor-
tae of ecNOS KO mice, suggesting an adaptive mechanism
similar to the one we observed. Nevertheless, in these ani-
mals, an increased expression of cyclooxygenase-2 over-
came the decrease of ETA  and enabled and increased
sensitivity to ET-1 [32].
Conclusion
This study has demonstrated the capacity of adaptation of
the endothelin system in a model of perfused isolated
liver in ecNOS KO mice. The mechanisms involved in this
adaptive response involve a decreased hepatic expression
of the ETA receptor in the absence of NO, leading to an
attenuation of the vasoconstriction induced by ET-1.
These data suggest that ETA may be one major player in the
regulation of hepatic vascular resistance. The expression
of ETA, which is increased in cirrhotic livers [33], may
hence represent a major pharmacological target to amel-
iorate portal pressure due to the imbalance between vaso-
constrictive and vasodilative mechanisms. Experimental
data on the use of ETA blockers in an animal model of por-
tal hypertension corroborate this hypothesis [34].
Methods
Animals
ecNOS knockout mice [13] were obtained from Dr. P. L.
Huang and bred locally. Wild type mice of the same
genetic background (C57BL/6J) served as controls. The
mice, all of male sex, were kept under a 12 h dark-light
cycle with free access to mouse chow and drinking water.
The protocol was approved by a state board on animal
experimentation; all experiments were performed accord-
ing to international guidelines concerning the conduct of
animal experimentation.
In situ liver perfusion
On the day of experimentation, mice were anesthetized
with pentobarbital (70 mg/kg), intra-peritoneal. Five each
of knockout and wild type animals were studied. Mouse
liver perfusion was carried out in situ as described previ-
ously from these laboratories using a pressure head [35].
The perfusion medium consisted of Krebs-Ringer-bicarbo-
nate buffer containing bovine serum albumin (2 % w/v)
and dextrose (0.1 % w/v). After a warming up period of 20
minutes, baseline flow and pressure were recorded and
resistance calculated. Then, ET-1 was infused at increasing
Resistance in the in situ perfused mouse liver of wild type (❍ )  and ecNOS knockout () mice in response to endothelin 1 Figure 3
Resistance in the in situ perfused mouse liver of wild type (❍ ) 
and ecNOS knockout () mice in response to endothelin 1. 
Mean and one standard deviation are shown. * Denotes a 
statistically significant difference, as assessed by ANOVA.
Table 1: Expression of ET-1; ETA and ETB receptors in the liver of 
wild-type and ecNOS knock-out mice.
Wild-type ecNOS knock-out
mRNA for ET-1 14.8 ± 0.5 15.0 ± 0.2
mRNA for ETA† 9.9 ± 0.3 11.4 ± 0.3*
mRNA for ETB 11.5 ± 0.7 11.9 ± 0.3
All results are expressed as mean ± standard deviation (n = 6 animals 
per group). The two animal groups were compared by Student's t-
test. † the 1.5 cycle increase in ETA mRNA in ecNOS knock-out mice 
indicates a 65% decrease in mRNA compared to wild-type mice. * p = 
0.0005.Comparative Hepatology 2006, 5:9 http://www.comparative-hepatology.com/content/5/1/9
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concentrations (10-11 to 3 × 10-9 M), without recirculation;
after 10 minutes, flow and pressure were recorded again.
ALT and K+ release into the media were recorded as a
measure of viability of the perfused organ.
Biochemical analyses
Six animals each of the wild-type and ecNOS knock-out
group were anesthetized as described above. The livers
were removed; half was homogenized for protein deter-
mination and the other half used for RNA preparation
(vide infra). Homogenization was carried out in four vol-
umes of 0.25 mol/L sucrose at 4°C. Protein concentration
was determined according to Lowry [36].
Western blot
Western blots were performed as previously reported [37].
In short, proteins from liver homogenate were separated
by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis using a 5% polyacrylamide gel for NOS or 12%
gel for HO and subsequently transferred to nitrocellulose
membranes. The membranes were blocked overnight with
BSA at 4°C and probed for 2 hours with the primary anti-
body. Antibodies against iNOS and ecNOS were obtained
from Transduction Laboratories (Lexington KY, USA) and
antibodies against HO1 and HO2 from StressGen Bio-
technologies (Victoria, Canada). HO1 (Hsp32) recom-
binant protein, OSP-500 recombinant human HO2
protein (both from StressGen Biotechnologies) and
mouse macrophage lysate iNOS (Transduction Laborato-
ries) were used as positive controls. The membranes were
washed twice with phosphate-buffered saline, incubated
for 1 hour with peroxidase-conjugated secondary anti-
body (IgG anti-rabbit), and detected by enhanced chemi-
luminescence (ECL Western Blot kit from Amersham Life
Science). Luminometric analysis of Western blots were
performed on Luminescent image analyzer LAS-1000
(Fujifilm) and expressed as LAU.
Radioimmunoassay of ET-1
Radioimmunoassay of ET-1 in liver tissue was as
described from our laboratories [38]. Briefly, snap frozen
tissue was homogenized in a chloroform-ethanol 2:1
solution with 0.1% trifluoroacetic acid and 1 mM N-ethyl-
maleamide. To each tube a volume of 40% of sterile water
was added and centrifuged at 48°C, 3900 g for 15 min.
The aqueous phase was collected, diluted 1:9 in acetic acid
4% and passed through activated Sep-Pak C18 500 mg
cartridges (Waters Corporation, Milford, USA). The prod-
uct of elution (2 ml 86% ethanol/4% acetic acid) was
dried overnight in a Speed-Vac centrifuge system.
Endothelin-1 was then analyzed by a double antibody
radioimmunoassay technique. Endothelin-1 was
obtained from Sigma (St. Louis, USA), ET-1 antibodies
were from Peninsula (St. Helens, England), and [125I]-
ET-1 was obtained from Amersham International (Buck-
inghamshire, UK).
RNA extraction and quantitation
Total RNA was isolated using the guanidinium isocyanate
method [39]. Five µg of total RNA were reverse transcribed
in a final volume of 20 µL using the Moloney Murine
Leukemia Virus Reverse Transcriptase (Gibco Life Tech-
nologies, USA). The Perkin-Elmer 7700 Sequence Detec-
tion System (Rotkreuz, Switzerland) for the quantitative
polymerase chain reaction assay was used. This is based
on the principle of detection of specific PCR products with
fluorogenic probes [40,41]. as previously described from
our laboratories [38]. Briefly, the probe contains a fluores-
cent reporter dye covalently linked to the 5' end, and a
quencher dye linked close to the 3' end. The closeness of
the quencher to the reporter emitter means that the
reporter fluorescence is suppressed. During PCR cycling,
the probe specifically hybridizes to the corresponding
template and is then cleaved via the 5' to 3' exonuclease
activity of Taq DNA polymerase. This cleavage results in
an increase of fluorescence emission of the reporter dye
proportional to the amount of specific PCR product. The
sequences of the probes and primers were designed
according to the manufacturer's guidelines and are
reported in Table 2. The threshold cycle (CT) of the mRNA
of interest (target) was expressed with reference to the CT
of internal Glyseraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA (∆CT = target CT - GAPDH CT).
Statistical analysis
All results are reported as mean ± 1 standard deviations.
Means of the two groups were compared by Student's t-
test. Normality was verified by studying normal quantile
Table 2: Primers and probes used in real-time PCR.
Gene Forward primer Probe Reverse primer
PreproET1 tggtggaaggaaggaaactacg aggttggaggccatcagcaacagc ttgcaacacgaaaagatgcc
ETA tgacctccccatcaacgtg ttaagctcttggcaggacgctggc tccaaaatcattgtggtcgaaa
ETB cgtgttcgtgctaggcatca cgggaactccacgctgctaagaatcat ttgcgcatgcacttgttctt
GAPDH actggcatggccttccg ttcctacccccaatgtgtccgtcgt caggcggcacgtcagatc
ecNOS ctgcaaaccgtgcagagaatt tggcaacagagggcggcatg caccggcttcatccagct
iNOS ggcagcctgtgagacctttg tgtccgaagcaaacatcacattcagatcc ttgcattggaagtgaagcgtt
Adrenomedullin cagggttcccgcagca atgccgcttcgggacctgca tagatctggtgggccaatttctComparative Hepatology 2006, 5:9 http://www.comparative-hepatology.com/content/5/1/9
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plots (QQ plots). Dose-response curves were analyzed by
analysis of variance with regression. A p < 0.05 was con-
sidered statistically significant.
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